Literature DB >> 15306649

Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.

Yo Muraki1, Akihiro Yamanaka, Natsuko Tsujino, Thomas S Kilduff, Katsutoshi Goto, Takeshi Sakurai.   

Abstract

Both orexin and serotonin (5-HT) have important roles in the regulation of sleep-wakefulness, as well as in feeding behavior. We examined the effects of 5-HT on orexin/hypocretin neurons, using hypothalamic slices prepared from orexin/enhanced green fluorescent protein (EGFP) transgenic mice in which EGFP is expressed exclusively in orexin neurons. Patch-clamp recording from EGFP-expressing cells showed that 5-HT hyperpolarized all orexin neurons in a concentration-dependent manner. The response was inhibited by the 5-HT1A receptor antagonist WAY100635. A 5-HT1A receptor agonist, 8-hydroxy-2-(dl-N-propyl-amino)tetralin, also evoked hyperpolarization on orexin neurons with potency comparable with 5-HT. A low concentration of Ba2+ (30 microM) inhibited 5-HT-induced hyperpolarization. Single-channel recording revealed that the conductance of 5-HT-induced channel activity was 33.8 pS, which is in good agreement with that of the G-protein-coupled inward rectifier potassium channel (GIRK). Moreover, 5-HT1A receptor-like immunoreactivity was observed on orexin neurons, and 5-HT transporter immunoreactive nerve endings are in close apposition to orexin neurons. Intracerebroventricular injection of the 5-HT1A receptor-selective antagonist WAY100635 (100 ng) increased locomotor activity during the latter half of dark phase in wild-type mice but not in orexin/ataxin-3 mice in which orexin neurons are specifically ablated, suggesting that activation of orexin neurons is necessary for the WAY100635-induced increase in locomotor activity. These results indicate that 5-HT hyperpolarizes orexin neurons through the 5-HT1A receptor and subsequent activation of the GIRK and that this inhibitory serotonergic input to the orexin neurons is likely to be important for the physiological regulation of this neuropeptide system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306649      PMCID: PMC6729168          DOI: 10.1523/JNEUROSCI.1027-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

1.  Influence of inhibitory serotonergic inputs to orexin/hypocretin neurons on the diurnal rhythm of sleep and wakefulness.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Thomas S Kilduff; Shouta Sugio; Ming Xu; Kenji F Tanaka; Satoru Takahashi; Makoto Tominaga; Akihiro Yamanaka
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons.

Authors:  Loris L Ferrari; Daniel Park; Lin Zhu; Matthew R Palmer; Rebecca Y Broadhurst; Elda Arrigoni
Journal:  J Neurosci       Date:  2018-01-08       Impact factor: 6.167

3.  Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus.

Authors:  Irene Morganstern; Guo-Q Chang; Jessica R Barson; Zhiyu Ye; Olga Karatayev; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

4.  GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus.

Authors:  Xinmin Xie; Tara L Crowder; Akihiro Yamanaka; Stephen R Morairty; Robin D Lewinter; Takeshi Sakurai; Thomas S Kilduff
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

Review 5.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture.

Authors:  Taizo Matsuki; Mika Nomiyama; Hitomi Takahira; Noriko Hirashima; Satoshi Kunita; Satoru Takahashi; Ken-ichi Yagami; Thomas S Kilduff; Bernhard Bettler; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

7.  Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep.

Authors:  Bende Zou; William S Cao; Zhiwei Guan; Kui Xiao; Conrado Pascual; Julian Xie; Jingxi Zhang; James Xie; Frank Kayser; Craig W Lindsley; C David Weaver; Jidong Fang; Xinmin Simon Xie
Journal:  Sleep       Date:  2019-03-01       Impact factor: 5.849

Review 8.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

9.  Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons.

Authors:  Norifumi Shioda; Yoshiki Imai; Yasushi Yabuki; Wataru Sugimoto; Kouya Yamaguchi; Yanyan Wang; Takatoshi Hikida; Toshikuni Sasaoka; Michihiro Mieda; Kohji Fukunaga
Journal:  J Neurosci       Date:  2019-08-01       Impact factor: 6.167

10.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.